Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2022	Jul. 31, 2021
Cash flows from operating activities:
Net income	$ 265,400	$ 374,240	$ 1,138,243
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation	144,601	136,120	127,507
Amortization of intangibles	132,544	140,808	156,946
Amortization of debt issuance costs and extinguishment charges	18,274	11,455	11,322
Deferred income tax benefit	(24,970)	(34,477)	(51,885)
Gain on disposition of property, plant and equipment	(9,597)	(3,319)	(7,564)
Stock-based compensation expense	37,901	39,512	31,421
Changes in assets and liabilities:
Accounts receivable	(60,153)	313,410	39,247
Inventories	236,916	109,975	(381,543)
Prepaid income taxes, expenses and other	(26,840)	1,052	(13,884)
Accounts payable	(101,910)	(120,684)	(116,608)
Accrued liabilities and other	(85,081)	295	78,385
Long-term liabilities and other	18,463	13,246	(21,471)
Net cash provided by operating activities	545,548	981,633	990,116
Cash flows from investing activities:
Purchases of property, plant and equipment	(139,635)	(208,194)	(242,357)
Proceeds from dispositions of property, plant and equipment	24,927	13,655	16,067
Business acquisitions, net of cash acquired	(7,314)	(6,184)	(781,967)
Other	(24,790)	(21,760)	(41,000)
Net cash used in investing activities	(146,812)	(222,483)	(1,049,257)
Cash flows from financing activities:
Borrowings on term-loan credit facilities	186,723	0	0
Payments on term-loan credit facilities	(340,619)	(402,355)	(332,907)
Borrowings on revolving asset-based credit facilities	113,502	0	660,088
Payments on revolving asset-based credit facilities	(111,555)	(100,000)	(559,035)
Proceeds from issuance of senior unsecured notes	0	0	500,000
Payments on other debt	(11,152)	(11,968)	(11,535)
Payments of debt issuance costs	(10,480)	0	(8,445)
Cash dividends paid	(102,137)	(95,969)	(94,944)
Payments on finance lease obligations	(755)	(1,215)	(1,084)
Purchase of treasury shares	(68,387)	(42,007)	(165,107)
Payments related to vesting of stock-based awards	(16,245)	(7,316)	(18,011)
Other	23,428	25,145	(16,861)
Net cash used in financing activities	(337,677)	(635,685)	(47,841)
Effect of exchange rate changes on cash and cash equivalents	(975)	6,214	(30,171)
Net increase (decrease) in cash and cash equivalents	60,084	129,679	(137,153)
Cash and cash equivalents, beginning of period	501,316	441,232	311,553	$ 448,706
Cash and cash equivalents, end of period	501,316	441,232	311,553	$ 448,706
Supplemental cash flow information:
Income taxes paid	147,126	143,077	380,874
Interest paid	86,421	95,383	74,455
Non-cash investing and financing transactions:
Capital expenditures in accounts payable	$ 5,429	$ 5,447	$ 4,733